Get insights into key studies identified by experts that were presented at the 2022 EHA annual meeting. The CCO EHA Conference Coverage program will have the information you need to understand and integrate the latest oncology data into your clinical practice.
Download this summary slideset covering high-impact data for key studies in hematologic cancers as presented at the 2022 EHA annual meeting.
Review expert perspectives and insights on the most clinically important data presented at EHA 2022 for acute myeloid leukemia, chronic lymphocytic leukemia, follicular lymphoma, multiple myeloma, and Waldenström macroglobulinemia.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.